Meta AnalysisID 2551
氨基葡萄糖的使用与结直肠癌风险：一项系统评价和Meta分析
CRD42022321739
This study is to explore whether glucosamine use is related to the occurrence of colorectal cancer and whether it can be used as a protective factor.
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 2551
- Evidence Id
- 11109
- Core Evidence Id
- 11109
- Source Meta Analysis Id
- 2499
- Herb2 Meta Analysis Id
- HBMA002499
- Crd Id
- CRD42022321739
- Title
- The use of Glucosamine and colorectal cancer risk: a systematic review and meta-analysis
- Review Question
- This study is to explore whether glucosamine use is related to the occurrence of colorectal cancer and whether it can be used as a protective factor.
- Study Type Included
- Randomized controlled trials (RCTs), cohort study and case-control study will be included.
- Condition Being Studied
- Human colorectal cancer is a common malignant tumor that causes a substantial burden worldwide. In 2018, there were an estimated 1.8 million new cases of colorectal cancer, accounting for 10.2% of new cases worldwide, and nearly 0.8 million deaths, accounting for 9.2% of global deaths. Many lifestyle factors, such as smoking, alcohol consumption, being overweight or obese, and physical inactivity contribute to an increased risk of colorectal cancer. Although there have been important advances in colorectal cancer treatment, such as surgery, radiotherapy, chemotherapy and immunotherapy, the prognosis continues to be poor for patients with advanced colorectal cancer.
- Participant
- Adults with glucosamine use will be included.
- Animal
- Human Disease Modelled
- Intervention
- Regular glucosamine use in adults.
- Comparator Control
- Adults without use glucosamine.
- Main Outcome
- Colorectal cancer diagnosed in hospital or other cancer；90 years of age,；death；end of the study. Measures of effect RR/OR
- Outcome Measure
- Additional Outcome
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Colorectal Neoplasms; Glucosamine; Humans
- Contact
- Yan Zhou [email protected]
- Organisational Affiliation
- Mianyang Central Hospital
- Funding Source
- No funding
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2022-03-29
- Registration Date
- 2022-04-29
- Anticipated Start Date
- 2022-03-25
- Anticipated Completion Date
- 2022-12-31
- Title Cn
- 氨基葡萄糖的使用与结直肠癌风险：一项系统评价和Meta分析
- Title En
- The use of Glucosamine and colorectal cancer risk: a systematic review and meta-analysis
- Bilingual Status
- complete